Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory ...
How eye-tracking complements verbal behavior assessment The VB-MAPP is one of the most widely used assessments in applied behavior analysis, and for good reason. It gives BCBAs a structured, […] ...
(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, ...
In 2017, a woman suffered severe vision impairment after gazing at a partial solar eclipse without protective eyewear. This ...
On the afternoon of 21 August 2017, millions of people across the United States looked towards the Sun as the Moon moved across it. For most viewers, the eclipse became a short-lived memory once the ...
Figures show that approximately one in five motorists should wear glasses to drive to ensure they are safe on the road. Many ...
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry ...
Jeffrey S. Farrow (CFO & Chief Strategy Officer) reported, "In the second quarter, XDEMVY net product sales were $173.9 million," with "Gross margins ... approximately 93%," and said Tarsus ended Q2 ...
Barclays is acting as exclusive financial advisor to Tarsus and Jefferies is acting as exclusive financial advisor to Alkeus. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is acting as ...
6d
Fossil study finds vision—not the 'thinking' frontal lobe—drove varied brain development in primates
A new study led by a Duke University scientist overturns a long-held idea about how primates, including humans, came to have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results